1970.

Podravka is starting to prepare for pharmaceutical-chemical production ie creates the prerequisites for entering a new strategic business area

1971.

The first modern medicine factory is built.

1972.

First Belupo medicine factory, started to operate in the fall of 1972. in Ludbreg. The factory starts growing.

1980.

Rapid development and spreading the production program condition building a new factory in Koprivnica, where the headquarters is still located today.

1981.

In 1981. with the new medicine factory in Danica, a new growth period began. In Belupo's production program in the 1980s a very important novelty was introducing the cosmetic product production.

1982.

In 1982. Belupo already offered a variety of products for export, which documented the widening of production. Needed conditions, for modern production and a widened variety of human and veterinarian medicinal products, were met.

1991.

Organization restructuring, meaning a new medicine factory and production program growth

1996.

Belupo, with constant production and business results growth and ambitious development plans, reached its 25th anniversary

1999.

Building a new 7000 square meters rigid medicine factory is the biggest and most important building in Belupo's 15000 square meters pharmaceutical complex. The factory enables an uninterrupted process of operational procedures, i.e. material and worker flow through physically connected spaces, which makes it unique in this part of Europe. Pros: closed system, impossibility of operator and substance contact, gravitational dosing, flexible and quick medicine substitute to meet the market demands, saving and innovation in trial production, graded production flow, modular concept which allows capacity upgrade, integrated warehouses with computer supervision.

2002.

Subsidiary with the headquarters in Ljubljana founded in Slovenia

2003.

Crystal ball for the Event project of the year, FESTO 2001., Opatija, Croatia

OTC NEWS Marketing & Creative Award 2002, Copenhagen, Denmark; Grand Global The Best In Healthcare Communication Worldwide 2002, The New York Festivals, New York, USA

Subsidiary with the headquarters in Bratislava founded in Slovakia

2004.

The most modern factory at the time, it was a response to the challenges of the globalized market. So-called Clean Rooms account for 1,760 square meters of the total floor area of 2,035 square meters. All manufacturing activities are compliant with the GMP standards and FDA’s regulations and the annual capacity of this new factory is 50 million packages.

2005.

A Quality Control and Assurance facility was built on 2,400 m2. By consolidating the Microbiological Laboratory and the Research and Quality Control Departments, we ensured that our departments critical for product quality and development operate efficiently.

2007.

Founding of a pharmaceutical institution - DELTIS phram (11 pharmaceutical units)

2008.

Gaining the majority stake in Farmavita - a pharmaceutical company in Bosnia and Herzegovina

2009.

Belupo won the "Golden key" for the best Croatian exporter to Bosnia and Herzegovina

2012.

Belupo wins a Crystal Statue and receives a Partner Employer Certificate from Selectio Group for the fifth time in a row.

Neofen was proclaimed the winning brand of the Trusted Brands survey for the third time in a row in the Analgesics category.

2013.

Belupo enlarges its drug storage capacities.

A business model was designed that uses the Food & Pharmaceuticals synergy in developing food with supplemental health benefits in addition to basic nutritive values.

Representations in Poland, Ukraine and Kazakhstan founded

Belupo receives a Golden Kuna as the most successful large company in Koprivnica-Križevci County.

Farmavita was selected The Most Desirable Employer in a survey organized by Development Studio and the Posao.ba portal.

2014.

The Ministry of Economy designates Belupo Incentive Measures Owner for the New Drug Factories project.

Belupo is issued a drug wholesale authorization and license.

Farmavita – The Most Desirable Employer in the Pharmaceutical Industry in Bosnia and Herzegovina in 2014.

Farmavita establishes its Representative Office in Priština, Kosovo.

2015.

Belupo's solid and semi-solid medicine factory four year construction finished

Lupocet receives a Best Buy Award Health 2014/2015 in the Headache Medications category.

Neofen’s radio campaign termed Announcement proclaimed the best campaign at the Effie & IdejaX Communication Days and receives an award in the Health, Beauty & Fashion category.

A Cooperation Agreement was signed with the Faculty of Pharmacy and Biochemistry of the University of Zagreb for scientific/technical and teaching activities.

Farmavita establishes its Representative Office in Priština, Kosovo.

2016.

Belupo’s Factories of the Future receive an occupancy permit.

Belupo receives a Certificate of Appreciation for supporting the scientific efforts of the Croatian Academy of Medical Sciences.

2017.

Belupo receives a Lider Invest award for continuous investment in a competition for the best large, medium-sized and small production investments.

Belupo was awarded a Digital Certificate of A+ Creditworthiness Excellence for 2017.

Belupo’s factory for solid, semisolid and liquid dosage forms, covering 20,608 m2, was completed after four years of construction. The New Factories are currently the largest greenfield investment in Croatia, worth over HRK 535 million. Belupo’s New Factories of the Future are equipped with state-of-the-art technology resulting in making value-added medications.

2018.

Belupo won the "Golden key" for the best Croatian exporter to Bosnia and Herzegovina

Belupo and Ruđer Bošković Institute signed a scientific & technical cooperation agreement.

Lider Invest 2018 – Belupo received an award for the Best Manufacturing Investment in the Republic of Croatia in 2017.

2019.

Serialization implemented
After comprehensive and time-consuming efforts on this project, a new era began for Belupo – serialization of prescription medicines in compliance with the requirements defined in Directive EU 2011/62 and Commission Delegated Regulation (EU) 2016/161 onprotection of medicinal products against falsification.

Belupo receives a Golden Key award
On 5 June 2019, as part of the 14th Croatian Exporters’ Convention held on the subject of “The Role of Exports in Modern Economic Policies”, the Croatian Exporters’ Association presented Belupo with a Gold Key award for being the best exporter to the Russian Federation market in 2018.

Hrvoje Kolarić appointed to the Executive Board of the Croatian Employers’ Association
At its last meeting held in May, the Council of the Croatian Employers’ Association (CEA) unanimously elected Hrvoje Kolarić, a Management Board member in Podravka and Chairman of the Management Board in Belupo, a member of its Executive Board, which isa joint organ responsible for managing CEA’s business.

ISO 9001:2015 Certificate
On 12 June 2019, the certification firm SGS Adriatica d.o.o. completed its audit of Belupo’s Quality System and decided to award it an ISO 9001:2015 certificate, being part of the international standard applicable to Quality Management Systems. This major recognition for Belupo reflects the conformity of its Quality System to the standard and fully confirms its process-based philosophy and focus on the customer.

ISO 13485:2016 Certificate
On 4 October, the certification firm UDEM Adriatic d.o.o. awarded Belupo a Certificate under ISO 13485:2016, an internationally recognized standard for Quality Management Systems in the pharmaceutical industry. ISO 13485 includes specific requirements for medical devices, such as design, manufacturing, quality control, storage, sale, and distribution.

Russian Regulatory Authority’s GMP inspection
Russian Regulatory Authority’s GMP inspectors carried out their activities in Belupo from 2December to 6 December for GMP certificate renewal purposes. This inspection is performed every 3 years and the Russian GMP Certificate allows Belupo to freely export its medicines to and market them in Russia in the next period.

Good Manufacturing Practice (GMP)
Inspectors of the Croatian Agency for Medicinal Products and Medical Devices (HALMED)audited all systems according to EudraLex - Volume 4 - Good Manufacturing Practice (GMP) Guidelines Part I, under all chapters and annexes, and found Belupo to satisfy the relevant GMP requirements, which means it is allowed to distribute its medicinal products in the European Union and on other markets that recognize such EU GMP Certificate.

AAA Credit Rating Excellence Certificate 2019
ISO 13485:2016 CertificateOn 4 October, the certification firm UDEM Adriatic d.o.o. awarded Belupo a Certificate under ISO 13485:2016, an internationally recognized standard for Quality Management Systems in the pharmaceutical industry. ISO 13485 includes specific requirements for medical devices, such as design, manufacturing, quality control, storage, sale, and distribution. Russian Regulatory Authority’s GMP inspectionRussian Regulatory Authority’s GMP inspectors carried out their activities in Belupo from 2December to 6 December for GMP certificate renewal purposes. This inspection is performed every 3 years and the Russian GMP Certificate allows Belupo to freely export its medicines to and market them in Russia in the next period. Good Manufacturing Practice (GMP)Inspectors of the Croatian Agency for Medicinal Products and Medical Devices (HALMED)audited all systems according to EudraLex - Volume 4 - Good Manufacturing Practice (GMP) Guidelines Part I, under all chapters and annexes, and found Belupo to satisfy the relevant GMP requirements, which means it is allowed to distribute its medicinal products in the European Union and on other markets that recognize such EU GMP Certificate. AAA Credit Rating Excellence Certificate 2019

2020.

CERTIFICATIONS OF THE QUALITY MANAGEMENT SYSTEM
Two scheduled ISO 9001:2015 and ISO 13485:2016 certifications/annual audits ofthe Quality Management System were performed in 2020. Considering thepersisting circumstances caused by the SARS Cov-19 virus pandemic andauditor’s inability to appear in person, these audits were conducted via a webplatform (Microsoft Teams).

TIHOMIR HEĐEVER APPOINTED TO BELUPO’SMANAGEMENT BOARD
Tihomir Heđever, M.Econ., was appointed a new reinforcement to the two-manManagement Board. Tihomir Heđever joined the company after working atmultinational auditors KPMG where he was Senior Manager at the AuditDepartment. He is an experienced project manager with a proven track record,having served some fifty clients as a financial advisor for 12 years. He has gainedsubstantial experience in due diligence activities and was also involved in aclient’s secondary equity offering. He also conducted and supervised numerousaudit engagements. He is an active member of the UK-based ACCA, a global bodyfor professional accountants.